BRAINSTORM CELL THERAPEUTICS INC. POS AM, filed Aug 11, 2010: v189603_ex5.htm
EXHIBIT
5
BRL Law
Group LLC
425
Boylston Street, 3rd
Floor
Boston,
Massachusetts 02116
August 11,
2010
BrainStorm
Cell Therapeutics Inc.
110 East
59th
Street
New York,
New York 10022
|
Re:
|
Registration Statement on Form
S-8
|
Ladies
and Gentlemen:
This
opinion is furnished to you in connection with a Post-Effective Amendment No. 1
on Form S-8 (the “Post-Effective Amendment”) to a Registration Statement on Form
S-8 (the “Registration Statement”) filed with the Securities and Exchange
Commission under the Securities Act of 1933, as amended (the “Securities Act”),
relating to shares of Common Stock, $.00005 par value per share (the “Shares”),
of Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”)
issued or issuable upon the exercise of stock options originally reserved for
issuance under (i) the Brainstorm Cell Therapeutics Inc. 2004 Global Share
Option Plan and (ii) the Brainstorm Cell Therapeutics Inc. 2005 U.S. Stock
Option and Incentive Plan (collectively, the “Assumed Shares”). The Assumed
Shares have been assumed by the Company pursuant to the Agreement and Plan of
Merger dated November 28, 2006 between the Company and Brainstorm Cell
Therapeutics Inc., a Washington corporation.
We have
examined the Certificate of Incorporation of the Company and the By-Laws of the
Company, each as amended to date, and originals, or copies certified to our
satisfaction, of all pertinent records of the meetings (and written consents in
lieu thereof) of the directors and stockholders of the Company, the
Post-Effective Amendment and such other documents relating to the Company as we
have deemed material for the purposes of this opinion. In our examination of the
foregoing documents, we have assumed the genuineness of all signatures, the
authenticity of all documents submitted as originals, the conformity to original
documents of all documents submitted as copies, the authenticity of the
originals of such latter documents and the legal competence of all signatories
to such documents.
We
express no opinion herein as to the laws of any state or jurisdiction other than
the Delaware Constitution, the Delaware General Corporation Law statute,
reported judicial decisions interpreting Delaware law and the federal laws of
the United States of America.
It is
understood that this opinion is to be used only in connection with the offer and
sale of the Assumed Shares covered by the Post-Effective Amendment while the
Registration Statement is in effect.
Based
upon and subject to the foregoing, we are of the opinion that the Assumed Shares
have been duly authorized for issuance and, when the Assumed Shares are issued
and paid for in accordance with the terms and conditions of the Amended and
Restated 2004 Global Share Option Plan and the Amended and Restated 2005 U.S.
Stock Option and Incentive Plan, the Assumed Shares will be validly issued,
fully paid and nonassessable.
We hereby
consent to the filing of this opinion as an exhibit to the Post-Effective
Amendment in accordance with the requirements of Item 601(b)(5) of Regulation
S-K under the Securities Act. In giving such consent, we do not hereby admit
that we are in the category of persons whose consent is required under Section 7
of the Securities Act or the rules and regulations of the
Commission.
|
Very
truly yours,
|
|
|
/s/
BRL Law Group LLC
|
|
|
BRL
Law Group LLC
|